Therapeutic Asset Ratings
164 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Abbv-324
Non-Small Cell Squamous Lung Carcinoma
AbbVie
P1
CC
(43)
Abbv-400
Biliary Tract Cancer
AbbVie
P1
CC
(43)
Abbv-400
Head And Neck Squamous Cell Carcinoma
AbbVie
P1
CC
(43)
Abbv-400
Ovarian Carcinoma
AbbVie
P1
CC
(43)
Abbv-525
B-Cell Neoplasm
AbbVie
P1
CC
(43)
Abbv-637
Advanced Solid Tumors Cancer
AbbVie
P1
CC
(43)
Abbv-637
Non-Small Cell Lung Carcinoma
AbbVie
P1
CC
(43)
Abbv-711
Squamous Cell Carcinoma
AbbVie
P1
CC
(43)
Abbv-950
Upper Limb Spasticity
AbbVie
P1
CC
(43)
Azirkitug
Gastroesophageal Cancer
AbbVie
P1
CC
(43)
Azirkitug
Ovarian Serous Adenocarcinoma
AbbVie
P1
CC
(43)
Budigalimab
Squamous Cell Carcinoma
AbbVie
P1
CC
(43)
Budigalimab
Gastroesophageal Cancer
AbbVie
P1
CC
(43)
Budigalimab
Ovarian Serous Adenocarcinoma
AbbVie
P1
CC
(43)
Docetaxel
Advanced Solid Tumors Cancer
AbbVie
P1
CC
(43)
GILORALIMAB
Advanced Solid Tumors Cancer
AbbVie
P1
CC
(43)
GILORALIMAB
Non-Small Cell Lung Carcinoma
AbbVie
P1
CC
(43)
Immunoglobulin G4 [234-proline], anti-(human protein GARP-transforming growth factor ?1 complex) (human monoclonal ABBV-151 ?4-chain), disulfide with human monoclonal ABBV-151 ?-chain, dimer
Advanced Solid Tumors Cancer
AbbVie
P1
CC
(43)
Itraconazole
Biliary Tract Cancer
AbbVie
P1
CC
(43)
Itraconazole
Head And Neck Squamous Cell Carcinoma
AbbVie
P1
CC
(43)
Levonorgestrel
Healthy Volunteer
AbbVie
P1
CC
(43)
MAB HUMANIZED (IGG1) ANTI P43489 (TNR4_HUMAN) (ABBV368)
Non-Small Cell Lung Carcinoma
AbbVie
P1
CC
(43)
ORSYTHIA COMPONENT ETHINYL ESTRADIOL
Healthy Volunteer
AbbVie
P1
CC
(43)
Osimertinib
Advanced Solid Tumors Cancer
AbbVie
P1
CC
(43)
Panobinostat
Advanced Solid Tumors Cancer
AbbVie
P1
CC
(43)
Showing 76 to 100 of 164 assets
Previous
Page 4 of 7
Next
